Company location
Tokyo, Japan
TAKEDA PHARMACEUTICAL CO LTD has filed 676 SEC EDGAR filings since 05 Mar 2007

SEC filing history

Showing 351-375 of 662 matching filings.

Per page
25
Current page
15
6-K File 001-38757

FORM 6-K

Filing date
19 Apr 2022
Reporting date
19 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
14 Apr 2022
Reporting date
14 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
13 Apr 2022
Reporting date
13 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
01 Apr 2022
Reporting date
01 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
01 Apr 2022
Reporting date
01 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
22 Mar 2022
Reporting date
22 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39094

FORM 4

Filing date
16 Mar 2022
Reporting date
14 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
14 Mar 2022
Reporting date
14 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
01 Mar 2022
Reporting date
01 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
14 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
10 Feb 2022
Reporting date
10 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90834

AMENDMENT NO. 1

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
03 Feb 2022
Reporting date
03 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
03 Feb 2022
Reporting date
03 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
03 Feb 2022
Reporting date
03 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90834

SC 13G/A filing

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
14 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
14 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
14 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
13 Jan 2022
Reporting date
13 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
11 Jan 2022
Reporting date
11 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
11 Jan 2022
Reporting date
11 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
05 Jan 2022
Reporting date
05 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
27 Dec 2021
Reporting date
27 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
16 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .